Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


LABORATORY CP   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2020201920182017201620152014201320122011
Period End Date12/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/201412/31/201312/31/201212/31/2011
Sales13,978.5011,554.8011,333.4010,308.009,552.908,505.706,011.605,808.305,671.405,542.30
Reimbursable out-of-pocket expenses----------174.40--------
Total Revenues13,978.5011,554.8011,333.4010,308.009,552.908,680.106,011.605,808.305,671.405,542.30
Cost of sales9,025.708,302.308,157.007,216.206,698.905,602.403,808.503,585.103,421.703,267.60
Reimbursable out-of-pocket expenses----------174.40--------
Gross Profit4,952.803,252.503,176.403,091.802,854.002,903.302,203.102,223.202,249.702,274.70
Goodwill and other asset impairments462.10------------------
Amortization of intangibles and other assets275.40243.20231.70216.50179.50164.5076.7081.7086.3085.80
Selling, general and administrative expenses1,729.301,624.501,570.901,499.201,345.501,628.101,204.301,128.801,114.601,159.60
Restructuring and other special charges40.6054.6048.1070.9058.40113.9017.8021.8025.3080.90
Operating Income (Loss)2,445.401,330.201,325.701,305.201,270.60996.80904.30990.901,023.50948.40
Interest expense207.40240.70244.20235.10219.10274.90109.5096.5094.5087.50
Loss on sale of assets--------------------
Income from equity investments2.909.8011.60----10.00------9.50
Equity method income, net------11.307.90--14.3016.9021.40--
Interest income----------------1.00--
Investment income10.308.807.502.101.701.901.102.20--1.30
Investment loss--------------------
Other income (expense), net(32.10)(3.20)167.70(6.00)12.50(7.80)10.402.10(7.20)(5.60)
Income from joint venture partnerships, net--------------------
Termination of interest rate swap agreement--------------------
Loss on early debt termination--------------------
Pre-Tax Income - Domestic1,846.50784.40937.70838.80884.50--752.50844.20909.00834.00
Pre-Tax Income - Foreign372.50320.50330.60238.70189.10--68.1071.4035.2032.10
Pre-Tax Income2,219.101,104.901,268.301,077.501,073.60726.00820.60915.60944.20866.10
Current- Foreign81.0083.9064.3053.0043.9069.4022.7022.5016.906.80
Current: Federal455.30126.70225.80300.80235.10218.30233.60231.60254.10269.70
Current: State172.8040.2061.2032.9038.6033.7024.0029.9035.1054.30
Deferred: Federal(6.70)38.20(2.50)(547.80)54.60(14.10)29.1055.2058.305.00
Deferred: State(28.10)2.5030.0011.405.30(4.20)3.706.100.40(4.40)
Deferred: Foreign(12.20)(11.50)5.60(5.70)(16.80)(15.80)(5.10)(5.10)(5.40)1.60
Provision for Income Taxes - Total662.10280.00384.40(155.40)360.70287.30308.00340.20359.40333.00
Earnings before extraordinary loss--------------------
Consolidated Net Income (Loss)1,557.00824.90883.901,232.90712.90438.70512.60575.40584.80533.10
Less net earnings attributable to noncontrolling interest0.901.100.205.801.101.101.401.601.7013.40
Less preferred stock dividends--------------------
Less accretion of mandatorily redeemable preferred stock--------------------
Net Income (Loss) Available to Common Shareholders1,556.10823.80883.701,227.10711.80437.60511.20573.80583.10519.70
Basic earnings per common share before extraordinary loss--------------------
Net Earnings Per Share (Basic)15.998.428.7111.996.944.436.036.366.095.20
Diluted earnings per common share before extraordinary loss--------------------
Net Earnings Per Share (Diluted)15.888.358.6111.816.824.355.916.255.995.11
Weighted Average Shares Outstanding (Basic)97.3097.90101.40102.40102.5098.8084.8090.2095.70100.00
Weighted Average Shares Outstanding (Diluted)98.0098.60102.60103.90104.30100.6086.4091.8097.40101.80